Skip to main content
OpenTrials

Clinical trial condition

Lymphoma, Non-Hodgkin

Explore clinical trials studying Lymphoma, Non-Hodgkin. Study availability and eligibility vary by location and protocol.

1,630 public trials 214 recruiting studies
Refine in advanced search Browse all conditions

Lymphoma, Non-Hodgkin trial results

Completed

Allo-hNHL (FluBuCy)

NCT00785330

Conditions
Disease Attributes, Graft vs Host Disease, Hemic and Lymphatic Diseases, +16 more
Locations
  • Universitätsklinikum Heidelberg Heidelberg, Baden-Würtenberg, Germany
  • Universitätsklinikum Marburg Marburg, Hesse, Germany
  • Universitätsklinikum und Poliklinik Homburg, Saarland, Germany
  • University Hospital Goettingen Göttingen, Germany
View Trial Details
Completed

Comprehensive Oncology Measures for Peripheral T-cell Lymphoma Treatment Registry

NCT01110733

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +9 more
Locations
  • DCH Cancer Treatment Center Tuscaloosa, Alabama, United States
  • Arizona Cancer Center Tucson, Arizona, United States
  • Genesis Cancer Center Hot Springs, Arkansas, United States
  • University of Arkansas for Medical Sciences Little Rock, Arkansas, United States
View all 68 locations
View Trial Details
Completed

A Study to Investigate the Efficacy and Safety of Bendamustine Compared With Bendamustine+Obinutuzumab (GA101) in Participants With Rituximab-Refractory, Indolent Non-Hodgkin's Lymphoma (GADOLIN)

NCT01059630

Conditions
Hemic and Lymphatic Diseases, Immune System Diseases, Immunoproliferative Disorders, +8 more
Locations
  • Southern Cancer Center, PC Mobile, Alabama, United States
  • Dr. Donald W. Hill, MD, FACP Casa Grande, Arizona, United States
  • Highlands Oncology Group Rogers, Arkansas, United States
  • Kaiser Permanente - Bellflower Bellflower, California, United States
View all 121 locations
View Trial Details
Completed

A Study of SB-743921 in Non-Hodgkin Lymphoma and Hodgkin Lymphoma

NCT00343564

Conditions
Hemic and Lymphatic Diseases, Hodgkin Disease, Hodgkin's Disease, +9 more
Locations
  • Hackensack University Medical Center Hackensack, New Jersey, United States
  • Cornell University Medical Center New York, United States
  • Memorial Sloan-Kettering Caner Center New York, United States
  • Herbert Irving Comprehensive Cancer Center New York, United States
View Trial Details
Completed

Study of Pralatrexate & Gemcitabine With B12 & Folic Acid to Treat Relapsed/Refractory Lymphoproliferative Malignancies

NCT00481871

Conditions
B-cell Lymphoma, Blood Protein Disorders, Cardiovascular Diseases, +33 more
Locations
  • University of California at Los Angeles Los Angeles, California, United States
  • Stanford University School of Medicine Stanford, California, United States
  • Rocky Mountain Cancer Center Denver, Colorado, United States
  • University of Chicago Hospital Chicago, Illinois, United States
View all 15 locations
View Trial Details
Completed

Donor Atorvastatin Treatment in Preventing Severe Acute GVHD After Nonmyeloablative Peripheral Blood Stem Cell Transplant in Patients With Hematological Malignancies

NCT01527045

Conditions
Aggressive Non-Hodgkin Lymphoma, Blasts Under 5 Percent of Bone Marrow Nucleated Cells, Blood Protein Disorders, +57 more
Locations
  • Presbyterian - Saint Lukes Medical Center - Health One Denver, Colorado, United States
  • Fred Hutch/University of Washington Cancer Consortium Seattle, Washington, United States
View Trial Details
Completed

Low-Dose Total Body Irradiation and Donor Peripheral Blood Stem Cell Transplant Followed by Donor Lymphocyte Infusion in Treating Patients With Non-Hodgkin Lymphoma, Chronic Lymphocytic Leukemia, or Multiple Myeloma

NCT00003196

Conditions
Adult Nasal Type Extranodal NK/T-cell Lymphoma, Anaplastic Large Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, +87 more
Locations
  • City of Hope Medical Center Duarte, California, United States
  • Stanford University Hospitals and Clinics Stanford, California, United States
  • Fred Hutchinson Cancer Research Center/University of Washington Cancer Consortium Seattle, Washington, United States
  • Universitaet Leipzig Leipzig, Germany
View Trial Details
Completed

Total-Body Irradiation and Fludarabine Phosphate Followed by Donor Peripheral Blood Stem Cell Transplant in Treating Patients With Hematologic Malignancies or Kidney Cancer

NCT00027820

Conditions
Adenocarcinoma, Adult Acute Myeloid Leukemia in Remission, Anemia, +72 more
Locations
  • University of Arizona Health Sciences Center Tucson, Arizona, United States
  • Stanford University Hospitals and Clinics Stanford, California, United States
  • Emory University/Winship Cancer Institute Atlanta, Georgia, United States
  • OHSU Knight Cancer Institute Portland, Oregon, United States
View Trial Details

Related conditions